NCT03002675View on ClinicalTrials.gov

Exenatide and Brown Adipose Tissue

PHASE4UnknownINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

June 30, 2018

Conditions

Obesity

Interventions

DRUG

Bydureon

exenatide (Bydureon) 2mg s.c. 1x/wk

Trial Locations (1)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Ingrid Jazet

OTHER